RMAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RMAX is not a good buy right now. The stock is in a clear bearish trend (stacked bearish moving averages and weakening MACD), and today’s price (7.68) is pressing into near-term support (~7.685), meaning downside risk is immediate if support breaks. While options positioning looks extremely call-heavy and the stock is somewhat oversold, there is no Intellectia buy signal to prioritize, and the next major catalyst (earnings) is still ahead—so the risk/reward is not attractive for an impatient buyer at this moment.
Trend/structure: Bearish. Moving averages are stacked bearish (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend.
Momentum: MACD histogram is negative (-0.0188) and expanding negatively, confirming weakening momentum.
RSI: RSI_6 at 34.3 suggests the stock is leaning toward oversold conditions (bounce potential), but not a confirmed reversal signal.
Key levels: Current price 7.68 is sitting right on S1 (7.685). A clean break below puts S2 (7.492) in play quickly. Upside resistance begins around Pivot (7.999) then R1 (~8.312).
Pattern-based forward bias: Similar-pattern stats imply only modest expected upside over a month (+2.62%) with weak near-term edge.
Intellectia Proprietary Trading Signals
showed sharply higher net income and EPS YoY, which can support a valuation reset if sustained.
becomes likely.
Latest quarter provided: 2025/Q3. Revenue: 73.25M, down -6.67% YoY (negative top-line trend). Net income: 3.99M, up +312.63% YoY (sharp improvement, likely driven by cost controls, non-operating items, or base effects). EPS: 0.19, up +280.00% YoY (profitability per share improved materially). Overall: Earnings improved strongly while revenue fell—good for near-term optics, but sustainability depends on whether profit gains can persist without top-line growth.
No analyst rating/price target change data was provided, so a concrete trend in upgrades/downgrades cannot be confirmed from this dataset. Wall Street-style pros view (inferred from fundamentals): improving EPS/net income, potential operational leverage, and a clear upcoming catalyst (earnings). Cons view: declining revenue, small-cap sensitivity to housing/transaction cycles, and a currently bearish chart trend that can overwhelm fundamentals in the short run.
